FDA inspection
Merck Serono SA: FDA inspection ending Jun 16, 2011
FDA inspection 732616 · Official Action Indicated (OAI) · Aubonne
Key facts
| Inspection ID | 732616 |
|---|---|
| Firm | Merck Serono SA |
| FEI number | 3002807447 |
| Address | Zone Industrielle, De L'Ouriettaz |
| City | Aubonne |
| Country | Switzerland |
| Fiscal year | 2011 |
| Inspection end date | Jun 16, 2011 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 214335 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data